Trial Profile

Effects of Oral Iron Supplementation Before vs. at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 01 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ad26.COV2 S (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Iron
Indications COVID 2019 infections; Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; SARS-CoV-2 acute respiratory disease
Focus Pharmacodynamics

Most Recent Events

23 Jan 2024 Planned End Date changed from 10 Jul 2024 to 30 Sep 2024.
23 Jan 2024 Planned primary completion date changed from 26 Mar 2024 to 30 Jun 2024.
16 Oct 2023 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com